Immunotherapy in Non-Small Cell Lung Cancer: The Past, the Present, and the Future

Thoracic Cancer - Australia
doi 10.1111/1759-7714.13012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy

The Lancet
Medicine
2019English

Lung Cancer Screening: Past, Present and Future

Frontiers in Respiratory Medicine
2017English

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy – Authors' Reply

The Lancet
Medicine
2019English

Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment

Juntendo Medical Journal
2019English

Pseudoprogression in Non–Small Cell Lung Cancer Upon Immunotherapy: Few Drops in the Ocean?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Review of Checkpoint Immunotherapy for the Management of Non-Small Cell Lung Cancer

ImmunoTargets and Therapy
AllergyImmunology
2018English

Non–small Cell Lung Cancer Predictive Biomarker Testing via Immunocytochemistry: Ways of Future Past?

Cancer cytopathology
Cancer ResearchOncology
2019English

Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Immunotherapy in Extensive Small Cell Lung Cancer

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy